Navamedic ASA
Ole Henrik Eriksen is a seasoned executive with extensive experience in business development and operations within the healthcare and pharmaceutical sectors. Currently serving as Chief Business Development Officer at Navamedic ASA since January 2019, Eriksen previously held the position of Chief Operating Officer and Founder at Novicus Pharma AS, and Chief Operating Officer at Weifa AS. Eriksen also contributed to companies such as Genetic Analysis AS as Chairman of the Board and Aqualis ASA as Chief Business Officer for Healthcare. With a significant tenure at Clavis Pharma ASA, Eriksen played a pivotal role as the first CEO and later as Chief Operating Officer. Educational credentials include a Master of Science in Organic Chemistry from the Norwegian University of Science and Technology (NTNU).
This person is not in any teams
Navamedic ASA
Navamedic is a reliable supplier of high-quality products, delivered to hospitals and through pharmacies, meeting the specific medical needs of patients and consumers. Our product portfolio consists of prescription and OTC pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. Navamedic is present in all Nordic countries, the Baltics and Benelux and has sales of specific products even in other European countries like UK and Greece. Our headquarter is in Oslo, Norway and we are listed on the Oslo Stock Exchange (ticker: NAVA). We are about 30 highly qualified employees with strong competence in regulatory affairs, quality assurance, reimbursement, marketing and sales and thus a full-service provider securing market access through our local competence.